Tranzyme Inc.
This article was originally published in Start Up
Executive Summary
The founders of Tranzyme Inc. believe that since HIV can infect and transfer its DNA into a wide range of cell types, by rendering the virus pathologically ineffective, they could turn the virus into an effective delivery system for gene therapy.